Puma Biotechnology (PBYI) Earnings Date & Reports

Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

PBYI is expected to report earnings to fall 67.44% to 14 cents per share on July 31

Puma Biotechnology PBYI Stock Earnings Reports

Q2'25

Est.

$0.14

Q4'24

Beat

by $0.32

Q3'24

Beat

by $0.13

Q2'24

Est.

$-0.05

Q1'24

Beat

by $0.12

The last earnings report on February 27 showed earnings per share of 43 cents, beating the estimate of 10 cents. With 146.88K shares outstanding, the current market capitalization sits at 150.88M.

View a ticker or compare two or three

Compare

PBYI